Identification of bacteria isolated from nasal polyps and their ability to produce superantigens and biofilms in Lebanese patients

Ear, Nose and Throat Journal

Volumn 90, Issue 4, 2011, Pages

  Chakhtoura, Marita ^a   Hadi, Usamah ^a   Rameh, Charbel ^a   Nassar, Jihad ^a   Abdelnoor, Alexander M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS ENTEROTOXIN C; STAPHYLOCOCCUS ENTEROTOXIN D; SUPERANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIOFILM; CHRONIC DISEASE; CITROBACTER KOSERI; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROBACTER AEROGENES; FEMALE; HUMAN; LEBANON; MALE; NOSE POLYP; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RHINOSINUSITIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; TISSUE CULTURE TECHNIQUE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY;

ADOLESCENT; AGED; BIOFILMS; CITROBACTER KOSERI; ENTEROBACTER AEROGENES; FEMALE; HUMANS; LEBANON; MALE; MIDDLE AGED; NASAL POLYPS; PROTEUS MIRABILIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; YOUNG ADULT;

EID: 79955632347     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556131109000413     Document Type: Article

References (33)

1. Lund VJ. Diagnosis and treatment of nasal polyps. BMJ 1995; 311 (7017): 1411-14.
2. Bachert C, Gevaert P, Holtappels G, et al. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107 (4): 607-14.
3. Bachert C, Patou J, Van Cauwenberge P. The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol 2006; 6 (1): 29-36.
4. Van Cauwenberge P, Van Hoecke H, Bachert C. Pathogenesis of chronic rhinosinusitis. Curr Allergy Asthma Rep 2006; 6 (6): 487-94.
5. Pawliczak R, Lewandowska-Polak A, Kowalski ML. Pathogenesis of nasal polyps: An update. Curr Allergy Asthma Rep 2005; 5 (6): 463-71.
6. Bachert C, van Zele T, Gevaert P, et al. Superantigens and nasal polyps. Curr Allergy Asthma Rep 2003; 3 (6): 523-31.
7. Van Cauwenberge P, Gevaert P, Van Hoecke H, et al. New insights into the pathology of nasal polyposis: The role of superantigens and IgE [in Dutch]. Verh K Acad Geneeskd Belg 2005; 67 (1): 5-28; discussion 29-32.
8. Thomas M, Yawn BP, Price D, et al. EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007-a summary. Prim Care Respir J 2008; 17 (2): 79-89.
9. Brook I, Frazier EH. Bacteriology of chronic maxillary sinusitis associated with nasal polyposis. J Med Microbiol 2005; 54 (6): 595-7.
10. Hashemi M, Sadeghi MM, Omrani MR, Torabi MA. Microbiology and antimicrobial resistance in chronic resistant rhino sinusitis with or without polyp after functional endoscopic sinus surgery. Journal of Research in Medical Sciences 2005; 10 (3): 167-71.
11. Conley DB, Tripathi A, Seiberling KA, et al. Superantigens and chronic rhinosinusitis II: Analysis of T-cell receptor V beta domains in nasal polyps. Am J Rhinol 2006; 20 (4): 451-5.
12. Van Zele T, Vaneechoutte M, Holtappels G, et al. Detection of enterotoxin DNA in Staphylococcus aureus strains obtained from the middle meatus in controls and nasal polyp patients. Am J Rhinol 2008; 22 (3): 223-7.
13. Tripathi A, Kern R, Conley DB, et al. Staphylococcal exotoxins and nasal polyposis: Analysis of systemic and local responses. Am J Rhinol 2005; 19 (4): 327-33.
14. Ajib R, Janbazian L, Rahal E, et al. HLA allele associations and V-beta T-lymphocyte expansions in patients with psoriasis, harboring toxin-producing Staphylococcus aureus. J Biomed Biotechnol 2005; 2005 (4): 310-15.
15. Janbazian L, [El-Ferzli] JC, Chakhtoura M, et al. Superantigen-producing strains of Staphylococcus aureus and Streptococcus isolated from human leukocyte antigen-Cw6-positive Lebanese patients with psoriasis [abstract]. Tissue Antigens 2008; 71 (4): 340.
16. Schlievert PM, Jablonski LM, Roggiani M, et al. Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals. Infect Immun 2000; 68 (6): 3630-4.
17. Bernstein JM, Ballow M, Schlievert PM, et al. A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 2003; 17 (6): 321-6.
18. Conley DB, Tripathi A, Seiberling KA, et al. Superantigens and chronic rhinosinusitis: Skewing of T-cell receptor V beta-distributions in polyp-derived CD4+ and CD8+ T cells. Am J Rhinol 2006; 20 (5): 534-9.
19. Wang M, Shi P, Chen B, et al. The role of superantigens in chronic rhinosinusitis with nasal polyps. ORL J Otorhinolaryngol Relat Spec 2008; 70 (2): 97-103.
20. Seiberling KA, Grammer L, Kern RC. Chronic rhinosinusitis and superantigens. Otolaryngol Clin North Am 2005; 38 (6): 1215-36, ix.
21. Seiberling KA, Conley DB, Tripathi A, et al. Superantigens and chronic rhinosinusitis: Detection of staphylococcal exotoxins in nasal polyps. Laryngoscope 2005; 115 (9): 1580-5.
22. Al-Daccak R, Mehindate K, Damdoumi F, et al. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors. J Immunol 1998; 160 (1): 225-32.
23. Herman A, Kappler JW, Marrack P, Pullen AM. Superantigens: Mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991; 9:745-72.
24. Kotzin BL, Leung DY, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv Immunol 1993; 54:99-166.
25. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248 (4956): 705-11.
26. Sanclement JA, Webster P, Thomas J, Ramadan HH. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 2005; 115 (4): 578-82.
27. Sanderson AR, Leid JG, Hunsaker D. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope 2006; 116 (7): 1121-6.
28. Christensen GD, Simpson WA, Younger JJ, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985; 22 (6): 996-1006.
29. [El-Ferzli] J, [Janbazian] L, Rubeiz N, et al. Streptococcus sp. and Staphylococcus aureus isolates from patients with psoriasis possess genes that code for toxins (superantigens): Clinical and therapeutic implications. Immunopharmacol Immunotoxicol 2008; 30 (2): 195-205.
30. Nooh MM, Aziz RK, Kotb M, et al. Streptococcal mitogenic exotoxin, SmeZ, is the most susceptible M1T1 streptococcal superantigen to degradation by the streptococcal cysteine protease, SpeB. J Biol Chem 2006; 281 (46): 35281-8.
31. Proft T, Fraser JD. Bacterial superantigens. Clin Exp Immunol 2003; 133 (3): 299-306.
32. Geha RS, Rosen FS. Case 26: Toxic shock syndrome.In: Geha RS, Rosen FS. Case Studies in Immunology: A Clinical Companion. 5th ed. New York; Oxford:Garland Science, Taylor & Francis Group; 2008:157-61.
33. Abdallah IM, Araj GF, Matar GM, et al. Polymerase chain reaction identification of coagulase-negative staphylococci and of strain diversity and spread of Staphylococcus epidermidis in a major medical center in Lebanon. Infect Control Hosp Epidemiol 2006; 27 (7): 781-3.